Interestingly, Motz et al. reported that VEGF could induce Fas Ligand expression in tumor endothelial cells, inhibiting cytotoxic T-lymphocyte (CTL) infiltration in the tumor and reducing their cytotoxic activity [24]. Here, VEGFA is linked to neoplasm.